Inhibition of Tau Polymerization with a Cyanine Dye in Two Distinct Model Systems*

In a host of neurodegenerative diseases Tau, a microtubule-associated protein, aggregates into insoluble lesions within neurons. Previous studies have utilized cyanine dyes as Tau aggregation inhibitors in vitro. Herein we utilize cyanine dye 3,3′-diethyl-9-methyl-thiacarbocyanine iodide (C11) to modulate Tau polymerization in two model systems, an organotypic slice culture model derived from Tau transgenic mice and a split green fluorescent protein complementation assay in Tau-expressing cells. In slice cultures, submicromolar concentrations (0.001 μm) of C11 produced a significant reduction of aggregated Tau and a corresponding increase in unpolymerized Tau. In contrast, treatment with a 1 μm dose promoted aggregation of Tau. These results were recapitulated in the complementation assay where administration of 1 μm C11 produced a significant increase in polymerized Tau relative to control, whereas treatment of cells with 0.01 μm C11 resulted in a marked reduction of aggregated Tau. In the organotypic slice cultures, modulation of Tau aggregation was independent of changes in phosphorylation at disease and microtubule binding relevant epitopes for both dosing regimes. Furthermore, treatment with 0.001 μm C11 resulted in a decrease in both total filament mass and number. There was no evidence of apoptosis or loss of synaptic integrity at either dose, however, whereas submicromolar concentrations of C11 did not interfere with microtubule binding, higher doses resulted in a decrease in the levels of microtubule-bound Tau. Overall, a cyanine dye can dissociate aggregated Tau in an ex vivo model of tauopathy with little toxicity and exploration of the use of these type of dyes as therapeutic agents is warranted.

[1]  J. Kuret,et al.  Structure-activity relationship of cyanine tau aggregation inhibitors. , 2009, Journal of medicinal chemistry.

[2]  E. Mandelkow,et al.  Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation* , 2008, Journal of Biological Chemistry.

[3]  G. Waldo,et al.  Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3β activation and caspase 3 cleavage , 2007, Journal of neurochemistry.

[4]  I. Grundke‐Iqbal,et al.  Site‐specific effects of tau phosphorylation on its microtubule assembly activity and self‐aggregation , 2007, The European journal of neuroscience.

[5]  E. Mandelkow,et al.  Inhibition of tau aggregation in cell models of tauopathy. , 2007, Current Alzheimer research.

[6]  M. Goedert,et al.  Interaction of tau protein with the dynactin complex , 2007, The EMBO journal.

[7]  Hermann Bujard,et al.  The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy* , 2007, Journal of Biological Chemistry.

[8]  J. Kuret,et al.  Potency of a tau fibrillization inhibitor is influenced by its aggregation state. , 2007, Archives of biochemistry and biophysics.

[9]  J. Biernat,et al.  N-phenylamine derivatives as aggregation inhibitors in cell models of tauopathy. , 2007, Current Alzheimer research.

[10]  Boris Schmidt,et al.  Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells. , 2007, Biochemistry.

[11]  V. Subramaniam,et al.  Cyanine dye-protein interactions: looking for fluorescent probes for amyloid structures. , 2007, Journal of biochemical and biophysical methods.

[12]  Qian Sun,et al.  Tau phosphorylation by GSK-3β promotes tangle-like filament morphology , 2007, Molecular Neurodegeneration.

[13]  John Q Trojanowski,et al.  High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation. , 2007, Biochemical and biophysical research communications.

[14]  J. Kuret,et al.  Tau Aggregation and Toxicity in a Cell Culture Model of Tauopathy* , 2007, Journal of Biological Chemistry.

[15]  S. Love,et al.  Neurofibrillary Tangles May Interfere With Smad 2/3 Signaling in Neurons , 2007, Journal of neuropathology and experimental neurology.

[16]  Y. Matsuoka,et al.  Organotypic slice cultures from transgenic mice as disease model systems , 2002, Journal of Molecular Neuroscience.

[17]  Mao-tsun Lin,et al.  PLATONIN, A CYANINE PHOTOSENSITIZING DYE, IS EFFECTIVE FOR ATTENUATION OF HEATSTROKE IN RATS , 2006, Shock.

[18]  N. Leclerc,et al.  Tau interacts with Golgi membranes and mediates their association with microtubules. , 2006, Cell motility and the cytoskeleton.

[19]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[20]  E. Mandelkow,et al.  Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy , 2006, Journal of Biological Chemistry.

[21]  Jean Féger,et al.  The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy , 2005, Journal of neurochemistry.

[22]  C. Chirita,et al.  Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases. , 2005, Biochemistry.

[23]  W. Noble,et al.  Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Mahindroo,et al.  Benzothiazolium compounds: novel classes of inhibitors that suppress the nitric oxide production in RAW264.7 cells stimulated by LPS/IFNgamma. , 2005, Bioorganic & medicinal chemistry letters.

[25]  C. Chirita,et al.  Triggers of full-length tau aggregation: a role for partially folded intermediates. , 2005, Biochemistry.

[26]  Takeshi Iwatsubo,et al.  Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins* , 2005, Journal of Biological Chemistry.

[27]  E. Mandelkow,et al.  Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells* , 2005, Journal of Biological Chemistry.

[28]  Martin von Bergen,et al.  Tau aggregation is driven by a transition from random coil to beta sheet structure. , 2005, Biochimica et biophysica acta.

[29]  J. Kuret,et al.  Electron microscopy as a quantitative method for investigating tau fibrillization. , 2004, Analytical biochemistry.

[30]  C. Chirita,et al.  Ligand-dependent inhibition and reversal of tau filament formation. , 2004, Biochemistry.

[31]  P. Cras,et al.  Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease , 2004, Acta Neuropathologica.

[32]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[33]  Sven Hellberg,et al.  Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418* , 2003, Journal of Biological Chemistry.

[34]  S. Techert,et al.  Photophysical properties of 3,3 '-diethylthiacarbocyanine iodide in binary mixtures , 2003 .

[35]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[36]  Bin Zhang,et al.  Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Morrison,et al.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease , 2003, Neurology.

[38]  Jesús Avila,et al.  Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. , 2003, Journal of Alzheimer's disease : JAD.

[39]  T. Hashikawa,et al.  Aberrant Tau Phosphorylation by Glycogen Synthase Kinase-3β and JNK3 Induces Oligomeric Tau Fibrils in COS-7 Cells* , 2002, The Journal of Biological Chemistry.

[40]  P. Coleman,et al.  Progressive Reduction of Synaptophysin Message in Single Neurons in Alzheimer Disease , 2002, Journal of neuropathology and experimental neurology.

[41]  E. Mandelkow,et al.  Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local β-Structure* , 2001, The Journal of Biological Chemistry.

[42]  W. Klunk,et al.  Inhibition of Polyglutamine Aggregation in R6/2 HD Brain Slices—Complex Dose–Response Profiles , 2001, Neurobiology of Disease.

[43]  Y. Barde,et al.  Neurotrophins are required for nerve growth during development , 2001, Nature Neuroscience.

[44]  J. Trojanowski,et al.  Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. , 2000, Molecular biology of the cell.

[45]  V. Ntziachristos,et al.  Hydrophilic Cyanine Dyes as Contrast Agents for Near-infrared Tumor Imaging: Synthesis, Photophysical Properties and Spectroscopic In vivo Characterization¶ , 2000, Photochemistry and photobiology.

[46]  E. Mandelkow,et al.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.

[47]  H. Lehrach,et al.  Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Davies,et al.  Characterization of Pathology in Transgenic Mice Over-Expressing Human Genomic and cDNA Tau Transgenes , 2000, Neurobiology of Disease.

[49]  Richard Hollister,et al.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.

[50]  M. Roth,et al.  Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Coleman,et al.  Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease , 1995, Neurobiology of Aging.

[52]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.